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Abstract The PA700-like proteasome activator complex was 
highly purified from porcine erythrocytes, and its properties were 
compared with those of the regulatory complex disassembled 
from the purified 26S proteasome. The molecular mass of the 
PA700-like complex, which comprises 25-110-kDa subunits, was 
estimated to be 800 kDa by Superose 6 gel filtration. This 
complex showed neither ATPase activity nor peptidase activity 
toward Suc-Leu-Leu-Val-Tyr-MCA. Nevertheless, it was 
possible to make a high molecular mass complex from the 
purified PA700-like complex by incubating with the 20S 
proteasome in the presence of ATP. In contrast, the regulatory 
complex dissociated from the 26S proteasome did not recon-
stitute a larger complex under the same conditions. The subunit 
composition of the PA700-like complex was similar but not 
identical to that of the regulator complex dissociated from the 
26S proteasome: the former complex had a 25-kDa subunit 
which is absent in the latter, whereas the latter had two or three 
43-kDa subunits lacking in the former. These results indicate 
that the purified PA700-like proteasome activator complex is 
structurally and functionally distinct from the regulatory 
complex dissociated from the 26S proteasome, implying the 
involvement of modulating factors in the 26S proteasome 
assembly. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Intracellular short-lived proteins or stress-induced abnor-
mal proteins are degraded by a ubiquitin (Ub1)-proteasome 
pathway [see reviews: [1-7]. In this pathway, substrate pro-
teins are specifically recognized and tagged with multi-Ub 
chains by El, E2 and E3, and they are subsequently degraded 
by the 26S proteasome [1-7]. Both ubiquitination and proteol-
ysis require ATP hydrolysis [1-7]. 
The 26S proteasome comprises two subcomplexes: the 20S 
proteasome and the 19-22S regulatory complex [1,5-7]. The 
former is a cylindrical 700-kDa proteolytic core complex 
stacked by four 7-subunit rings composed of 20-33-kDa sub-
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units, while the latter is a 700-1000-kDa regulatory complex 
containing ATPase subunits (S4 [8], S6 (TBP7) [9], S7 (MSS1) 
[10,11], TBP1 [12], p45 [13], and p42 [12,14]), an RNA-proc-
essing enzyme subunit (SI) [15], and a multi-Ub chain recog-
nizing subunit (S5a) [[16], see reviews: [7,17]]. The regulatory 
complex is currently known by different names such as an 
ATPase complex [18], (i, particle [19], 19S cap complex [20], 
or PA700 [21], but it is not clear whether these subcomplexes 
are mutually identical at the molecular level. 
Hershko and coworkers [22] first reported that the 26S pro-
teasome can be disassembled into three factors, CF-1 (600 
kDa), CF-2 (250 kDa) and CF-3 (650 kDa), in ATP-depleted 
reticulocyte lysates, and that these partially purified prepara-
tions are able to reconstitute the 26S proteasome in an ATP-
dependent manner. In addition, they reported that the as-
sembled 26S complex possesses ATPase activity but the dis-
assembled subcomplexes do not [23]. Later, CF-3 and CF-2 
were identified as the 20S proteasome [24] and an ATP-stabi-
lized inhibitor against the 20S proteasome [25], respectively; 
the latter is proposed to be a hexameric 40-kDa 8-aminolevu-
linic acid dehydratase [25]. In contrast to CF-2 and CF-3, 
CF-1 has not yet been completely purified, though it is 
thought to be an activator for the 20S proteasome [1]. 
Taken together, it seems likely that the 26S proteasome 
may dissociate into different subcomplexes under different ex-
perimental conditions. In addition to these issues, it is also 
unclear whether the regulatory complex and the 20S protea-
some, both of which are once disassembled from the purified 
26S proteasome, are capable of reconstituting the 26S protea-
some without the addition of any factor(s). 
In order to clarify these issues, we first attempted to recon-
stitute the 26S proteasome from the regulatory complex and 
the 20S proteasome, both of which had been isolated from the 
purified 26S proteasome by non-denaturing PAGE [26]. How-
ever, we failed to reconstitute the 26S proteasome from these 
two subcomplexes. Since the purified PA700 is reported to be 
capable of binding to the 20S proteasome, we assumed that a 
proteasome activator (PA700) may be a complex functionally 
distinct from the regulatory complex dissociated from the 26S 
proteasome (dRC), although these two complexes are similar 
in terms of subunit composition. 
In the present study, therefore, we attempted to purify the 
PA700-like proteasome activator complex from porcine eryth-
rocytes according to the procedure described by Chu-Ping et 
al. [21] with slight modification, and we compared its proper-
ties with those of dRC. The results clearly showed that our 
purified PA700-like complex has a proteasome activator ac-
tivity and an ability to make up a higher molecular mass 
complex with the 20S proteasome in an ATP-dependent man-
ner. In addition, it was found that this activator complex 
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possesses a unique 25-kDa subunit, which is absent in d R C , 
and that it lacks 43-kDa subunits, which are present in dRC. 
Taken together, we propose that putative modulat ing factors, 
which are not incorporated into the assembled 26S protea-
some, may function in the 26S proteasome assembly. 
2. Materials and methods 
2.1. Materials 
Suc-Leu-Leu-Val-Tyr-MCA and AMC were purchased from the 
Peptide Institute Inc. (Osaka, Japan). DEAE-cellulose (DE-32) and 
phosphocellulose (P-ll) are products of Whatman BioSystems. The 
FPLC system equipped with Mono Q (HR 5/5) and Superose 6 (HR 
10/30) is a product of Pharmacia AB Biotechnology. Hydroxylapatite 
column (Pentax column, 0.75 X10 cm) was obtained from TOSO. 
Prep Cell apparatus model 491 is a product of Bio-Rad Laboratories. 
2.2. Buffers 
Buffer A, 20 mM Tris-HCl (pH 7.6) containing 0.5 mM MgCl2, 
0.1 mM EDTA, 5 mM 2-mercaptoethanol, and 10% glycerol; Buffer 
B, 20 mM sodium phosphate (pH 7.6) containing 1 mM 2-mercapto-
ethanol, and 10% glycerol; Buffer C, 200 mM sodium phosphate 
(pH 7.6) containing 1 mM 2-mercaptoethanol, and 10% glycerol. 
2.3. Assay for enzymatic activities 
Hydrolysis of Suc-Leu-Leu-Val-Tyr-MCA was determined as pre-
viously described [26]. ATPase activity was assayed by quantifying the 
inorganic phosphate, which is released by ATP hydrolysis, essentially 
according to the method of Fiske and Sabbarow with some modifi-
cations [26]. 
2.4. Assay for proteasome activator activity 
Proteasome activator activity, which was MgATP-dependent, was 
assayed essentially according to [21]. Briefly, the activator fraction 
was previously incubated with the 20S proteasome at 37°C for 
60 min, and then proteasome activity was measured as described 
above. 
2.5. Protein determination and electrophoresis 
Protein concentration was determined by the method of Bradford 
[27] with bovine serum albumin as a standard. SDS-PAGE was car-
ried out according to the method of Laemmli [28]. In order to com-
pare the subunit compositions among the PA700-like activator com-
plex, dRC, and the 26S proteasome, 2D-PAGE (first dimension, 
NEPHGE; second dimension, SDS-PAGE) was carried out as de-
scribed by O'Farrell et al. [29] with slight modifications [26], 
2.6. Preparation of porcine erythrocyte ly sates 
Porcine fresh blood (3 1) was collected in a plastic vessel, in which 
had been placed one-fiftieth volume (60 ml) of 100 U/ml heparin 
dissolved in PBS, and the solution was gently mixed on ice. The blood 
was centrifuged at 2000 Xg for 10 min, and the resulting precipitate 
was washed 4 times with 3 volumes of PBS by centrifugation at 
2000Xg for 10 min. At this time, the buffy coat (mainly platelets 
and leukocytes) was removed by a pipette. The resulting precipitates, 
containing packed erythrocytes, were mixed with 2 volumes of 1 mM 
DTT and the solution was stirred for 30 min at 4°C. The erythrocyte 
lysates thus obtained were centrifuged at lOOOOXg for 1 h, and the 
supernatant was dialyzed against Buffer A containing 20 mM NaCl 
and used as a crude extract. 
2.7. Purification of20S and 26S proteasomes from porcine erythrocytes 
The 20S and 26S proteasomes were purified from the crude extract 
of porcine erythrocyte lysates essentially according to the method 
described previously from Fraction II [30]. 
2.8. Isolation of the regulatory complex from the 26S proteasome 
purified from porcine erythrocytes 
The regulatory complex (dRC) was isolated from the purified 26S 
proteasome by preparative non-denaturing PAGE according to the 
method of Laemmli [28], but in the absence of SDS, using a Bio-
Rad model 491 Prep Cell apparatus as previously described [26]. 
2.9. Purification of the PA700-like proteasome activator complex from 
porcine erythrocytes 
To the crude extract obtained from 3 1 of blood, 1 1 of DEAE-
cellulose wet gel equilibrated with Buffer A containing 20 mM NaCl 
was added. After stirring for 30 min, the gel was washed with the 
equilibration buffer using a glass filter, and the gel was then packed 
into a column (10x13 cm) followed by washing with 2.5 1 of the 
equilibration buffer. The adsorbed materials were eluted with 2 1 of 
Buffer A containing 500 mM NaCl. To the eluate (2.3 1, so-called 
Fraction II), ammonium sulfate was added at 38% saturation and 
stirred for 30 min. The insoluble materials were collected by centrifu-
gation (lOOOOXg, 30 min) and dissolved in 30 ml of Buffer A con-
taining 100 mM NaCl. This solution was divided into two parts, and 
each portion was applied to a Sephacryl S-300 column (3.6x55 cm) 
that had been previously equilibrated with Buffer A containing 
100 mM NaCl. Chromatography was carried out at a flow rate of 
60 ml/h, and 10-ml fractions were collected. Fractions showing pro-
teasome activator activity were collected and adsorbed to a Mono Q 
column (0.5X5 cm) that had been equilibrated with Buffer A contain-
ing 100 mM NaCl. After the column had been washed with the equi-
libration buffer, the adsorbed materials were eluted with 250 mM 
NaCl and then with a linear gradient of NaCl (250-400 mM; total 
volume, 8 ml) dissolved in Buffer A. The flow rate was 0.25 ml/min, 
and 1-ml fractions were collected. Activator activity was detected at 
about 330-350 mM NaCl. Active fractions were collected, dialyzed 
against Buffer B, and applied to a hydroxylapatite column 
(0.75x10 cm) equilibrated with Buffer B. After washing with the 
equilibration buffer, the adsorbed materials were eluted with a linear 
gradient generated by mixing Buffer C into Buffer B (total volume, 
25 ml). The flow rate was 0.25 ml/min, and 1-ml fractions were col-
lected. Activator activity was detected at a phosphate concentration of 
90 mM, and active fractions were concentrated with Centricon-10 up 
to 0.5 ml and placed on a Superose 6 column (1 X30 cm) that had 
been equilibrated with Buffer A containing 100 mM NaCl. The col-
umn was developed at a flow rate of 0.25 ml/min, collecting 0.5 ml in 
each tube. Activator activity was detected as a symmetrical peak, and 
active fractions were used as a purified preparation of the PA700-like 
activator complex. 
2.10. Molecular mass estimation 
The molecular mass of the PA700-like activator complex was esti-
mated by Superose 6 HR 10/30 FPLC using thyroglobulin (667 kDa), 
apoferritin (443 kDa) and alcohol dehydrogenase (150 kDa) as mo-
lecular mass standards. The column was equilibrated and developed 
with buffer C at a flow rate of 0.2 ml/min, and 0.5-ml fractions were 
collected. 
Table 1 
Properties of PA700-like activator complex, dRC, 26S proteasome and 20S proteasome purified from porcine erythrocytes 
Properties PA700-like complex d R C 26S proteasome 20S proteasome 
Molecular size (kDa) 
Subunit (kDa) 
Hydrolytic activity 
Suc-LLVY-MCA 
ATP 
Activator activity toward 20S proteasome 
Binding activity to 20S proteasome 
25-kDa subunit 
43-kDa subunits 
800 
25-110 
— 
+ 
Yes 
Yes 
Present 
Absent 
1100 
28-110 
— 
No 
No 
Absent 
Present 
~2000 
23-110 
++ 
++ 
Absent? 
Present 
700 
23-32 
+ 
— 
Absent 
Absent 
aRef. [26]. 
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Fig. 1. Superose 6 FPLC of the PA700-like activator complex obtained from the hydroxylapatite column. Left panel: The activator fractions 
eluted at about 90 mM phosphate on hydroxylapatite chromatography were collected and applied to a Superose 6 column (1 X 30 cm) that had 
been equilibrated with Buffer A containing 100 mM NaCl. Fractions (500 ul) were collected at a constant flow rate of 0.25 ml/min. Each frac-
tion was incubated at 37°C for 60 min with 20S proteasome, and proteasome activity toward Suc-Leu-Leu-Val-Tyr-MCA was measured as 
described in Section 2. Absorbance at 280 nm ( - • - ) ; Suc-Leu-Leu-Val-Tyr-MCA-hydrolyzing activity in the presence (- • -) or absence 
(- O -) of the 20S proteasome. The dashed line indicates the activity level of the 20S proteasome exogenously added. Right panel: SDS-PAGE 
of the purified PA700-like activator complex. Fifteen microliters of each Superose 6 fractions was subjected to SDS-PAGE (12.5% gel) accord-
ing to the method of Laemmli 28. 
3. Results 
3.1. Purification and purity of the PA700-like proteasome 
activator complex from porcine erythrocytes 
We first attempted to purify the PA700- or PA700-like pro-
teasome activator complex according to the method of Chu-
Ping et al. [21] with some modifications. 
The PA700-like proteasome activator complex was highly 
purified from porcine red blood cells by DEAE-cellulose chro-
matography, 0-38% ammonium sulfate fractionation, Se-
phacryl S-300 gel filtration, hydroxylapatite chromatography, 
Mono Q FPLC and Superose 6 FPLC. From 3 1 of porcine 
fresh blood, approximately 750 ug of the purified proteasome 
activator complex was obtained. In the last purification step 
on Superose 6 FPLC, proteasome activator activity was co-
incidently eluted with the protein peak, showing a constant 
specific activity (Fig. 1, left panel). 
Purity of the activator was examined by SDS-PAGE. As 
shown in Fig. 1 (right panel), the purified preparation gave 
several bands, all of which were eluted together at fractions 
23-25 (the highest amounts at fraction 24). This suggests that 
these subunit components are mutually associated and that 
the purity of our activator preparation is high. 
3.2. Characterization of the PA700-like activator complex 
The molecular mass of the activator complex was estimated 
to be 800 kDa by Superose 6 FPLC (see Fig. 1, left panel). 
SDS-PAGE gave at least 13 bands consisting of 4 bands with 
molecular masses of 110, 100, 29, and 25 kDa, and at least 9 
bands between 32 and 60 kDa (see Fig. 2, right panel). This 
SDS-PAGE pattern is very similar to that of PA700 reported 
previously [12,21] but not to that of dRC [26], since dRC does 
not have the 25-kDa subunit. It is reported that PA700 prep-
aration purified from bovine erythrocytes also contains the 
25-kDa subunit [21]. 
The purified activator preparation showed no activity to-
ward Suc-Leu-Leu-Val-Tyr-MCA, a preferred substrate for 
the 26S and 20S proteasomes, indicating that there is no con-
tamination of the 26S or the 20S proteasome in this prepara-
tion. In addition, little or no ATPase activity ( < 1% of the 
activity of the 26S proteasome) was detected in the PA700-like 
activator complex. 
In contrast to the report that ATPase activity is copurified 
with PA700 [21], Ganoth et al. [22] failed to detect significant 
ATPase activity in the disassembled CF-1, a similar complex 
to PA700. In connection to this, it should be noted that dRC 
also has no detectable ATPase activity, i.e. less than 0.1% of 
the ATPase activity of the 26S proteasome [26]. 
3.3. Comparison of subunit compositions among PA700-like 
activator complex, dRC, and 26S proteasome 
The subunit composition of the PA700-like activator com-
plex of porcine erythrocytes was analyzed by 2D-PAGE (first 
dimension, NEPHGE; second dimension, SDS-PAGE) and 
was compared with those of porcine erythrocyte dRC and 
26S proteasome. As shown in Fig. 2, the subunit composition 
of the PA700-like activator complex was distinct from that of 
dRC. The main differences are as follows: first, the 25-kDa 
subunit (pi, ~ 5.7) detected in the PA700-like complex is ab-
sent in dRC, and second, two or three 43-kDa subunits with 
slightly different isoelectric points (pi, ~ 6.5-7.0) detected in 
dRC and the 26S proteasome are absent in the PA700-like 
complex. 
3.4. The PA700-like activator complex but not the regulatory 
complex dissociated from 26S proteasome is capable of 
reconstituting a higher molecular mass complex with 20S 
proteasome 
It has been reported that the PA700 is capable of making 
up a higher molecular mass complex with the 20S proteasome 
in the presence of ATP [12]. Thus, we examined whether our 
PA700-like activator complex and the 20S proteasome can 
reconstitute the 26S proteasome (or a 26S proteasome-like 
high molecular mass complex) in the presence of ATP. As 
524 H. Sawada et al.lFEBS Letters 412 (1997) 521-525 
depicted in Fig. 3, proteasome activity was detected at a high-
er molecular size position (fraction 22), which corresponds to 
that of the 26S proteasome, than that of the 20S proteasome 
(elution position; fraction 25-26). In contrast to this, dRC 
was unable to form a higher molecular mass complex with 
the 20S proteasome (data not shown). These results indicate 
that the PA700-like activator complex, unlike dRC, can make 
a higher molecular mass complex with the 20S proteasome. 
Taken together, we conclude that the PA700-like activator 
complex is functionally and structurally different from the 
regulatory complex once dissociated from the 26S protea-
some, although these two complexes are similar in terms of 
their subunit compositions. 
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Fig. 2. 2D-PAGE (first dimension, NEPHGE; second dimension, 
SDS-PAGE) patterns of the PA700-like activator complex (A), dRC 
(B), and the 26S proteasome (C), all of which are purified prepara-
tions from porcine erythrocytes. On NEPHGE, pH gradient was 
made between pH 4 (left) and pH 9 (right). Note that the 25-kDa 
subunit (•&; pi, = 5.7) observed in the PA700-like complex is absent 
in dRC or the 26S proteasome, while two or three 43-kDa subunits 
(*; pi, =6.5-7.0) observed in the dRC and the 26S proteasome 
are not detected in the PA700-like complex. 
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Fig. 3. Formation of a higher molecular mass complex by incubat-
ing the 20S proteasome with (- • -) or without (- o -) the PA700-
like activator complex. The purified 20S proteasome (120 units) was 
mixed with or without 150 |xg of the PA700-like complex followed 
by incubation at 37°C for 60 min. These samples were subjected to 
Superose 6 FPLC in Buffer A containing 100 mM NaCl. Note that 
the higher molecular mass complex showing Suc-Leu-Leu-Val-Tyr-
MCA-hydrolyzing activity, which corresponds to the elution posi-
tion of the 26S proteasome, was newly formed by incubating the 
20S proteasome with the PA700-like complex, suggesting that the 
purified 20S proteasome and PA700-like complex preparations are 
capable of being associated with each other in the presence of ATP. 
4. Discussion 
From porcine erythrocytes, we succeeded in purifying a 
PA700-like proteasome activator complex with a molecular 
mass of 800 kDa, which is capable of forming a higher mo-
lecular mass complex by incubation with the 20S proteasome 
in the presence of ATP. We also showed that the purified 
PA700-like activator complex (800 kDa) is similar but not 
identical to the regulatory complex (1100 kDa) dissociated 
from the 26S proteasome reported previously [26], on the 
bases of molecular size and subunit composition: the dRC 
lacks a 25-kDa subunit detected in the PA700-like complex, 
while the former contained 43-kDa subunits lacking in the 
latter (Table 1). 
In our experimental conditions, little or no ATPase was 
detected in the completely purified PA700-like complex prep-
aration. In the purified dRC preparation also, we could not 
detect any ATPase activity in spite of the existence of ATPase 
subunits [26]. In contrast, a high ATPase activity was ob-
served in the purified porcine erythrocyte 26S proteasome 
(this study) and in the bovine erythrocyte PA700 [31]. The 
following three reasons are offered as possible explanations 
for this discrepancy in ATPase activity. Firstly, the ATPase 
activity in our PA700-like complex may have been diminished 
by inactivation or removal of some of the ATPase subunits 
during purification. Secondly, the ATPase activity contained 
in the PA700 preparation [31] may have been contaminated 
by non-related ATPases. Thirdly, ATPase activities may have 
been masked in our PA700-like complex and dRC, and these 
masked ATPases may have been activated after association 
with the 20S proteasome. Further study is necessary to clarify 
these points. 
The 20S proteasome was only partially shifted to the elu-
tion position of 26S proteasome on Superose 6 gel filtration 
after its incubation with PA700-like complex (Fig. 3). This 
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appears to be due to the partial dissociation of the high mo-
lecular mass proteasome complex, which was formed from the 
20S proteasome and PA700-like complex, since our prelimi-
nary data showed that the purified preparation of the 26S 
proteasome is partially dissociated into the constituent sub-
complexes on Superose 6 gel filtration even in the presence of 
0.1 mM ATP and 10% glycerol. Treatment of the assembled 
complex with cross-linking reagents or addition of an excess 
amount of PA700-like complex into the 20S proteasome 
would increase a yield of the higher molecular mass complex. 
Alternatively, the 43-kDa component of dRC- or ATP-de-
pendent modulator [12] may be necessary for the formation 
of stable complex. 
CF-1 (600 kDa) has not yet been purified, but CF-2 
(250 kDa) has been purified and identified as a homo-hexamer 
of 40 kDa. The purified PA700-like activator complex does 
not contain the two or three 43-kDa subunits that are present 
in dRC and the 26S proteasome. These results led us to as-
sume that the PA700-like complex may correspond to a com-
plex of CF-1 plus the 25-kDa subunit, and that the 43-kDa 
subunits that are absent in the PA700-like complex may cor-
respond to CF-2, i.e. 8-aminolevulinic acid dehydratase. The 
25-kDa subunit appears to be distinct from p27, a subunit of 
ATP-dependent modulator of PA700 [12], albeit they are sim-
ilar to each other in molecular mass, since it is reported that 
the purified PA700 does not contain p27 subunit [12]. In con-
nection to these issues, one intriguing hypothesis is that the 
25-kDa subunit may be a kind of molecular chaperon that 
stimulates the assembly of the 26S proteasome complex. Fur-
ther investigations on the identification of the above 25- and 
43-kDa subunits, as well as molecular elucidation of reconsti-
tution of the 26S proteasome from the PA700-like complex 
and 20S proteasome, are now in progress in our laboratory. 
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